A novel role of the CX3CR1/CX3CL1 system in the cross-talk between chronic lymphocytic leukemia cells and tumor microenvironment-Reference-Cited by-同舟云学术

A novel role of the CX3CR1/CX3CL1 system in the cross-talk between chronic lymphocytic leukemia cells and tumor microenvironment

Published:2011-05-06 Issue:8 Volume:25 Page:1268-1277
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Ferretti E,Bertolotto M,Deaglio S,Tripodo C,Ribatti D,Audrito V,Blengio F,Matis S,Zupo S,Rossi D,Ottonello L,Gaidano G,Malavasi F,Pistoia V,Corcione A

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu201188.pdf

Reference36 articles.

1. Chiorazzi N, Rai KR, Ferrarini M . Chronic lymphocytic leukemia. N Engl J Med 2005; 352: 804–815.

2. Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999; 94: 1840–1847.

3. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK . Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999; 94: 1848–1854.

4. Matrai Z . CD38 as a prognostic marker in CLL. Hematology 2005; 10: 39–46.

5. Crespo M, Bosch F, Villamor N, Bellosillo B, Colomer D, Rozman M et al. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med 2003; 348: 1764–1775.

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fractalkine in Health and Disease;International Journal of Molecular Sciences;2024-07-23

2. Contribution of the TIME in BCP-ALL: the basis for novel approaches therapeutics;Frontiers in Immunology;2024-01-17

3. The CX3CL1-CX3CR1 chemokine axis can contribute to tumor immune evasion and blockade with a novel CX3CR1 monoclonal antibody enhances response to anti-PD-1 immunotherapy;Frontiers in Immunology;2023-09-13

4. A systematic pan-cancer analysis reveals the clinical prognosis and immunotherapy value of C-X3-C motif ligand 1 (CX3CL1);Frontiers in Genetics;2023-04-20

5. Structure and Function of Ligand CX3CL1 and its Receptor CX3CR1 in Cancer;Current Medicinal Chemistry;2022-12